CDK5 Activation Drives Pancreatic Neuroendocrine Tumorigenesis and is a Therapeutic Target. (2021) - Carter, A.; Bibb, J.; Telange, R.; Howse, W.; Schrader, J.; Tan, C.; Robinson, B.; Reddy, S.